1. Home
  2. GLMD vs MYSE Comparison

GLMD vs MYSE Comparison

Compare GLMD & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • MYSE
  • Stock Information
  • Founded
  • GLMD 2000
  • MYSE 2014
  • Country
  • GLMD Israel
  • MYSE United States
  • Employees
  • GLMD N/A
  • MYSE N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • MYSE Telecommunications Equipment
  • Sector
  • GLMD Health Care
  • MYSE Telecommunications
  • Exchange
  • GLMD Nasdaq
  • MYSE Nasdaq
  • Market Cap
  • GLMD 7.5M
  • MYSE 8.9M
  • IPO Year
  • GLMD 2014
  • MYSE 2021
  • Fundamental
  • Price
  • GLMD $1.48
  • MYSE $2.09
  • Analyst Decision
  • GLMD Hold
  • MYSE
  • Analyst Count
  • GLMD 1
  • MYSE 0
  • Target Price
  • GLMD N/A
  • MYSE N/A
  • AVG Volume (30 Days)
  • GLMD 213.6K
  • MYSE 52.9K
  • Earning Date
  • GLMD 11-13-2025
  • MYSE 11-13-2025
  • Dividend Yield
  • GLMD N/A
  • MYSE N/A
  • EPS Growth
  • GLMD N/A
  • MYSE N/A
  • EPS
  • GLMD N/A
  • MYSE N/A
  • Revenue
  • GLMD N/A
  • MYSE $315.00
  • Revenue This Year
  • GLMD N/A
  • MYSE N/A
  • Revenue Next Year
  • GLMD N/A
  • MYSE N/A
  • P/E Ratio
  • GLMD N/A
  • MYSE N/A
  • Revenue Growth
  • GLMD N/A
  • MYSE N/A
  • 52 Week Low
  • GLMD $1.15
  • MYSE $1.15
  • 52 Week High
  • GLMD $23.80
  • MYSE $9.34
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 51.13
  • MYSE N/A
  • Support Level
  • GLMD $1.33
  • MYSE N/A
  • Resistance Level
  • GLMD $1.60
  • MYSE N/A
  • Average True Range (ATR)
  • GLMD 0.10
  • MYSE 0.00
  • MACD
  • GLMD 0.03
  • MYSE 0.00
  • Stochastic Oscillator
  • GLMD 66.67
  • MYSE 0.00

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About MYSE Myseum Inc. Common Stock

Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.

Share on Social Networks: